LMU Medizinische Fakultät IBE IBE
Suche:
Home  |  Sitemap  |  RSS RSS  |  www.lmu.de  |  Medizinische Fakultät  |  LMU-Portal
IBE - Institut für medizinische Informationsverarbeitung, Biometrie und Epidemiologie

2005

Lenz G, Dreyling M, Hoster E, Wormann B, Duhrsen U, Metzner B, Eimermacher H, Neubauer A, Wandt H, Steinhauer H, Martin S, Heidemann E, Aldaoud A, Parwaresch R, Hasford J, Unterhalt M, Hiddemann W
immunochemotherapy with rituximab and cyclophosphamide, doxorubicin, vincristine, and prednisone significantly improves response and time to treatment failure, but not long-term outcome in patients with previously untreated mantle cell lymphoma: results of a prospective randomized trial of the German Low Grade Lymphoma Study Group (GLSG)
J Clin Oncol, 23(9), 1984-92, 2005 - Impact-Factor 11.81
Haferlach T, Kohlmann A, Schnittger S, Dugas M, Hiddemann W, Kern W, Schoch C
Global approach to the diagnosis of leukemia using gene expression profiling
Blood, 106(4), 1189-98, 2005 - Impact-Factor 10.131
Dreyling M, Lenz G, Hoster E, Van-Hoof A, Gisselbrecht C, Schmits R, Metzner B, Truemper L, Reiser M, Steinhauer H, Boiron JM, Boogaerts MA, Aldaoud A, Silingardi V, Kluin-Nelemans HC, Hasford J, Parwaresch R, Unterhalt M, Hiddemann W
Early consolidation by myeloablative radiochemotherapy followed by autologous stem cell transplantation in first remission significantly prolongs progression-free survival in mantle-cell lymphoma: results of a prospective randomized trial of the European MCL Network
Blood, 105(7), 2677-84, 2005 - Impact-Factor 10.131
Barth AS, Merk S, Arnoldi E, Zwermann L, Kloos P, Gebauer M, Steinmeyer K, Bleich M, Kaab S, Hinterseer M, Kartmann H, Kreuzer E, Dugas M, Steinbeck G, Nabauer M
Reprogramming of the human atrial transcriptome in permanent atrial fibrillation: expression of a ventricular-like genomic signature
Circ Res, 96(9), 1022-9, 2005 - Impact-Factor 9.408
Schoch C, Kohlmann A, Dugas M, Kern W, Hiddemann W, Schnittger S, Haferlach T
Genomic gains and losses influence expression levels of genes located within the affected regions: a study on acute myeloid leukemias with trisomy 8, 11, or 13, monosomy 7, or deletion 5q
Leukemia, 19(7), 1224-8, 2005 - Impact-Factor 6.612
Kohlmann A, Schoch C, Dugas M, Schnittger S, Hiddemann W, Kern W, Haferlach T
New insights into MLL gene rearranged acute leukemias using gene expression profiling: shared pathways, lineage commitment, and partner genes
Leukemia, 19(6), 953-64, 2005 - Impact-Factor 6.612
Hasford J, Pfirrmann M, Hochhaus A
How long will chronic myeloid leukemia patients treated with imatinib mesylate live?
Leukemia, 19(4), 497-9, 2005 - Impact-Factor 6.612
Germing U, Hildebrandt B, Pfeilstocker M, Nosslinger T, Valent P, Fonatsch C, Lubbert M, Haase D, Steidl C, Krieger O, Stauder R, Giagounidis AA, Strupp C, Kundgen A, Mueller T, Haas R, Gattermann N, Aul C
Refinement of the international prognostic scoring system (IPSS) by including LDH as an additional prognostic variable to improve risk assessment in patients with primary myelodysplastic syndromes (MDS)
Leukemia, 19(12), 2223-31, 2005 - Impact-Factor 6.612
Berger U, Maywald O, Pfirrmann M, Lahaye T, Hochhaus A, Reiter A, Hasford J, Heimpel H, Hossfeld DK, Kolb HJ, Loffler H, Pralle H, Queisser W, Hehlmann R, German-CML-Study-Group
Gender aspects in chronic myeloid leukemia: long-term results from randomized studies
Leukemia, 19(6), 984-9, 2005 - Impact-Factor 6.612
Julg BD, Bogner JR, Crispin A, Goebel FD
Progression of renal impairment under therapy with tenofovir [3]
Aids, 2005 - Impact-Factor 5.835
Knaebel HP, Marten A, Schmidt J, Hoffmann K, Seiler C, Lindel K, Schmitz-Winnenthal H, Fritz S, Herrmann T, Goldschmidt H, Mansmann U, Debus J, Diehl V, Buchler MW
Phase III trial of postoperative cisplatin, interferon alpha-2b, and 5-FU combined with external radiation treatment versus 5-FU alone for patients with resected pancreatic adenocarcinoma -- CapRI: study protocol [ISRCTN62866759]
BMC Cancer, 5(1), 37, 2005 - Impact-Factor 4.8
Kohlmann A, Schoch C, Dugas M, Rauhut S, Weninger F, Schnittger S, Kern W, Haferlach T
Pattern robustness of diagnostic gene expression signatures in leukemia
Genes Chromosomes Cancer, 42(3), 299-307, 2005 - Impact-Factor 4.8
Haferlach T, Kohlmann A, Schnittger S, Dugas M, Hiddemann W, Kern W, Schoch C
AML M3 and AML M3 variant each have a distinct gene expression signature but also share patterns different from other genetically defined AML subtypes
Genes Chromosomes Cancer, 43(2), 113-27, 2005 - Impact-Factor 4.8
Giese T, Engstner M, Mansmann U, Hartschuh W, Arden B
Quantification of melanoma micrometastases in sentinel lymph nodes using real-time RT-PCR
J Invest Dermatol, 124(3), 633-7, 2005 - Impact-Factor 4.406
Kerr J, Engel J, Eckel R, Hoelzel D
Survival for rectal cancer patients and international comparisons
Ann Oncol, 16(4), 664-72, 2005 - Impact-Factor 4.319
Meissner PE, Coulibaly B, Mandi G, Mansmann U, Witte S, Schiek W, Muller O, Heiner-Schirmer R, Mockenhaupt FP, Bienzle U
Diagnosis of red cell G6PD deficiency in rural Burkina Faso. Comparison of a rapid fluorescent enzyme test on filter paper with polymerase chain reaction based genotyping
Br J Haematol, 131(3), 395-9, 2005 - Impact-Factor 4.08
Heldwein W, Dollhopf M, Rosch T, Meining A, Schmidtsdorff G, Hasford J, Hermanek P, Burlefinger R, Birkner B, Schmitt W
The Munich Polypectomy Study (MUPS): Prospective Analysis of Complications and Risk Factors in 4000 Colonic Snare Polypectomies
Endoscopy, 37(11), 1116-22, 2005 - Impact-Factor 4.072
Barth AS, Merk S, Arnoldi E, Zwermann L, Kloos P, Gebauer M, Steinmeyer K, Bleich M, Kaab S, Pfeufer A, Uberfuhr P, Dugas M, Steinbeck G, Nabauer M
Functional profiling of human atrial and ventricular gene expression
Pflugers Arch, 450(4), 201-8, 2005 - Impact-Factor 3.564
Huth KC, Paschos E, Hajek-Al-Khatar N, Hollweck R, Crispin A, Hickel R, Folwaczny M
Effectiveness of 4 pulpotomy techniques--randomized controlled trial
J Dent Res, 84(12), 1144-8, 2005 - Impact-Factor 3.192
Engel J, Kerr J, Eckel R, Gunther B, Heiss M, Heitland W, Siewert JR, Jauch KW, Hoelzel D
Influence of hospital volume on local recurrence and survival in a population sample of rectal cancer patients
Eur J Surg Oncol, 31(5), 512-20, 2005 - Impact-Factor 3.184
Chouker A, Martignoni A, Schauer R, Dugas M, Rau HG, Jauch KW, Peter K, Thiel M
Beneficial effects of ischemic preconditioning in patients undergoing hepatectomy: the role of neutrophils
Arch Surg, 140(2), 129-36, 2005 - Impact-Factor 3.053
Brand S, Staudinger T, Schnitzler F, Pfennig S, Hofbauer K, Dambacher J, Seiderer J, Tillack C, Konrad A, Crispin A, Goke B, Lohse P, Ochsenkuhn T
The role of Toll-like receptor 4 Asp299Gly and Thr399Ile polymorphisms and CARD15/NOD2 mutations in the susceptibility and phenotype of Crohn's disease
Inflammatory Bowel Diseases, 2005 - Impact-Factor 3.012
Klemke CD, Mansmann U, Poenitz N, Dippel E, Goerdt S
Prognostic factors and prediction of prognosis by the CTCL Severity Index in mycosis fungoides and Sezary syndrome
British Journal of Dermatology, 2005 - Impact-Factor 2.978
Bindewald A, SchmitzValckenberg S, Jorzik JJ, DolarSzczasny J, Sieber H, Keilhauer C, Weinberger AWA, Dithmar S, Pauleikhoff D, Mansmann U, Wolf S, Holz FG
Classification of abnormal fundus autofluorescence patterns in the junctional zone of geographic atrophy in patients with age related macular degeneration
British Journal of Ophthalmology, 2005 - Impact-Factor 2.459
Becker CR, Majeed A, Crispin A, Knez A, Schoepf UJ, Boekstegers P, Steinbeck G, Reiser MF
CT measurement of coronary calcium mass: Impact on global cardiac risk assessment
European Radiology, 2005 - Impact-Factor 2.437
Grau T, Kessler J, Mansmann U
Re: central venous catheterization in infants
Br J Anaesth, 94(1), 135; author reply 136-7, 2005 - Impact-Factor 2.425
Engel J, Kerr J, Eckel R, Gunther B, Heiss M, Heitland W, Jauch KW, Siewert JR, Hoelzel D
Quality of treatment in routine care in a population sample of rectal cancer patients
Acta Oncol, 44(1), 65-74, 2005 - Impact-Factor 2.362
Hasford J, Hass J, Firzlaff M
Twenty-four-month comparison of immunomodulatory treatments - a retrospective open label study in 308 RRMS patients treated with beta interferons or glatiramer acetate (Copaxone(R)). European Journal of Neurology 12:425-431
Eur J Neurol, 12(11), 916-7, 2005 - Impact-Factor 2.244
Meissner PE, Mandi G, Witte S, Coulibaly B, Mansmann U, Rengelshausen J, Schiek W, Jahn A, Sanon M, Tapsoba T, Walter-Sack I, Mikus G, Burhenne J, Riedel KD, Schirmer H, Kouyate B, Muller O
Safety of the methylene blue plus chloroquine combination in the treatment of uncomplicated falciparum malaria in young children of Burkina Faso [ISRCTN27290841]
Malar J, 4, 45, 2005 - Impact-Factor 2.137
Marquardt L, Ruf A, Mansmann U, Winter R, Buggle F, Kallenberg K, Grau AJ
Inflammatory response after acute ischemic stroke
Journal of the Neurological Sciences, 2005 - Impact-Factor 2.035
Mandi G, Witte S, Meissner P, Coulibaly B, Mansmann U, Rengelshausen J, Schiek W, Jahn A, Sanon M, Wust K, WalterSack I, Mikus G, Burhenne J, Riedel KD, Schirmer H, Kouyate B, Muller O
Safety of the combination of chloroquine and methylene blue in healthy adult men with G6PD deficiency from rural Burkina Faso
Tropical Medicine and International Health, 2005 - Impact-Factor 2.021
Bockler D, Blaurock P, Mansmann U, Schwarzbach M, Seelos R, Schumacher H, Allenberg JR
Early surgical outcome after failed primary stenting for lower limb occlusive disease
J Endovasc Ther, 12(1), 13-21, 2005 - Impact-Factor 1.805
Chouker A, Martignoni A, Schauer RJ, Dugas M, Schachtner T, Kaufmann I, Setzer F, Rau HG, Lohe F, Jauch KW, Peter K, Thiel M
Alpha-gluthathione S-transferase as an early marker of hepatic ischemia/reperfusion injury after liver resection
World J Surg, 29(4), 528-34, 2005 - Impact-Factor 1.601
Engel J, Hoelzel D
Axilläre Lymphonodektomie/Sentinel-Biopsie - unnötige Operation oder sinnvolle Maßnahme zur Prognoseabschätzung
Journal Onkologie, 08, 6-9, 2005 - Impact-Factor 1.206
Pfirrmann M, Hasford J
A simulation study using validated prognostic factors to assess expected long-term survival
Methods Inf Med, 44(4), 577-83, 2005 - Impact-Factor 0.97
Repsilber D, Mansmann U, Brunner E, Ziegler A
Editorial - Tutorial on microarray gene expression experiments: An introduction
Methods of Information in Medicine, 2005 - Impact-Factor 0.97
Mansmann U, Meister R
Testing differential gene expression in functional groups: Goeman's global test versus an ANCOVA approach
Methods of Information in Medicine, 2005 - Impact-Factor 0.97
Mansmann U
Genomic Profiling: Interplay between clinical epidemiology, bioinformatics and biostatistics
Methods of Information in Medicine, 2005 - Impact-Factor 0.97
Chouker A, Martignoni A, Schauer RJ, Rau HG, Volk A, Heizmann O, Dugas M, Messmer K, Peter K, Thiel M
Ischemic preconditioning attenuates portal venous plasma concentrations of purines following warm liver ischemia in man
Eur Surg Res, 37(3), 144-52, 2005 - Impact-Factor 0.755
Willgeroth F, Baumann M, Blaser D, Crispin A, Froschauer S, de-Waal J, Heywang-Kobrunner S, Hoelzel D, Kaab V, Rothe R, Stich V, Thomaschewski S, Walter D
Bayerisches Mammographiescreening (BMS)
Radiologe, 45(3), 264-8, 2005 - Impact-Factor 0.720
Trumm C, Dugas M, Wirth S, Treitl M, Lucke A, Kuttner B, Pander E, Clevert DA, Glaser C, Reiser M
Digitales Lehrarchiv Konzept, Implementation und Erfahrungen im universitaren Umfeld
Radiologe, 45(8), 724-34, 2005 - Impact-Factor 0.720
Lehnert M, Eberle A, Hentschel S, Katalinic A, Kieschke J, Schmidtmann I, Schubert-Fritschle G, Stegmaier C, Hense HW
Das maligne Melanom der Haut in epidemiologischen Krebsregistern in Deutschland -- Inzidenz, klinische Parameter, Variationen in der Erhebung
Gesundheitswesen, 67(10), 729-35, 2005 - Impact-Factor 0.548
Lang S, Rotter N, Lorenzen A, Ihrler S, Eckel R, Holzel D, Rasp G, Wollenberg B, Sommer K
Speicheldrusenkarzinome. Teil II: Diagnostik und Therapie
Hno, 53(10), 905-11; quiz 912-3, 2005 - Impact-Factor 0.484
Lang S, Rotter N, Lorenzen A, Ihrler S, Eckel R, Hoelzel D, Rasp G, Wollenberg B, Sommer K
Speicheldrusenkarzinome Teil I: Epidemiologie, Atiologie, Malignitatskriterien, Prognoseparameter und Klassifikation
Hno, 53(9), 817-26; quiz 827-8, 2005 - Impact-Factor 0.484
Schubert-Fritschle G, Weissbach L, Hoelzel D
Nachsorge oder keine Nachsorge - das ist hier die Frage!
Urologe A, 44(9), 991-6, 2005 - Impact-Factor 0.471
Deckert A, SchmitzValckenberg S, Jorzik J, Bindewald A, Holz FG, Mansmann U
Automated analysis of digital fundus autofluorescence images of geographic atrophy in advanced age-related macular degeneration using confocal scanning laser ophthalmoscopy (cSLO)
BMC Ophthalmology, 2005
Hasford J
CONTRA medikamentöse Alzheimer Therapie - Die Datenlage ist unzureichend!
DNP, 9-11, 2005
Dugas-Breit S, Schopf P, Dugas M, Schiffl H, Rueff F, Przybilla B
Baseline serum levels of mast cell tryptase are raised in hemodialysis patients and associated with severity of pruritus
J Dtsch Dermatol Ges, 3(5), 343-7, 2005
Müller TH
Central IT-Structures for Integrated Medical Research and Health Care of Viral Hepatitis - Hep-Net
Studies in Health Technology and Informatics, 116, 1016-20, 2005
Batschkus MM
Computer-Sicherheit und Internet
Bayerisches Ärzteblatt, 254-255, 2005
Batschkus MM
Fachliteratur im Internet
Bayerisches Ärzteblatt, 22-23, 2005
Schlesinger-Raab A, Eckel R, Engel J, Sauer H, Loehrs U, Molls M, Hoelzel D
Mammakarzinom: Keine Lebensverlängerung nach Metastasierung seit mehr als 20 Jahren?
Deutsches Ärzteblatt, 2706-2714, 2005
Hasford J, Pfirrmann M, Shepherd P, Guilhot J, Hehlmann R, Mahon FX, Kluin-Nelemans HC, Ohnishi K, Steegmann JL, Thaler J
The impact of the combination of baseline risk group and cytogenetic response on the survival of patients with chronic myeloid leukemia treated with interferon alpha
Haematologica, 90(3), 335-40, 2005
Hellenbrecht A, Gökbuget N, Müller TH
Nutzerumfragen
Leukämie Rundbrief, 2005
Dreyhaupt J, Mansmann U, Pritsch M, DolarSzczasny J, Bindewald A, Holz FG
Modelling the natural history of geographic atrophy in patients with age-related macular degeneration
Ophthalmic Epidemiology, 2005
Müller TH
Verbindung von Telemedizin und Forschung - Datenschutzgerechte Lösungen
Telemedizinführer Deutschland, Ober-Mörlen, 2005
Impressum - Datenschutz - Kontakt